SunLink Health Systems (NYSEAMERICAN:SSY) Downgraded by TheStreet to D+

SunLink Health Systems (NYSEAMERICAN:SSY) was downgraded by equities research analysts at TheStreet from a “c” rating to a “d+” rating in a research report issued to clients and investors on Wednesday, TheStreetRatingsTable reports.

Shares of NYSEAMERICAN:SSY opened at $3.09 on Wednesday. The company has a quick ratio of 1.95, a current ratio of 2.16 and a debt-to-equity ratio of 0.13. SunLink Health Systems has a 1 year low of $0.76 and a 1 year high of $7.62. The stock has a market cap of $21.38 million, a PE ratio of 14.05 and a beta of 1.15. The business’s 50-day moving average price is $1.19.

SunLink Health Systems (NYSEAMERICAN:SSY) last issued its earnings results on Friday, May 14th. The company reported ($0.07) earnings per share (EPS) for the quarter. SunLink Health Systems had a return on equity of 11.97% and a net margin of 3.71%. The firm had revenue of $9.78 million for the quarter.

In other SunLink Health Systems news, Director Howard E. Turner sold 53,421 shares of the company’s stock in a transaction that occurred on Friday, June 4th. The stock was sold at an average price of $3.12, for a total value of $166,673.52. Following the completion of the transaction, the director now owns 200,035 shares in the company, valued at approximately $624,109.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Howard E. Turner sold 100,000 shares of the company’s stock in a transaction that occurred on Friday, May 21st. The stock was sold at an average price of $2.86, for a total value of $286,000.00. Insiders have sold a total of 171,121 shares of company stock valued at $505,774 in the last quarter. Company insiders own 44.50% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP purchased a new position in shares of SunLink Health Systems during the 1st quarter valued at approximately $41,000. Geode Capital Management LLC boosted its stake in shares of SunLink Health Systems by 191.2% during the 1st quarter. Geode Capital Management LLC now owns 29,199 shares of the company’s stock valued at $79,000 after buying an additional 19,172 shares during the last quarter. Citadel Advisors LLC purchased a new position in shares of SunLink Health Systems during the 1st quarter valued at approximately $77,000. Renaissance Technologies LLC boosted its stake in shares of SunLink Health Systems by 22.2% during the 4th quarter. Renaissance Technologies LLC now owns 322,245 shares of the company’s stock valued at $409,000 after buying an additional 58,500 shares during the last quarter. Finally, Acadian Asset Management LLC boosted its stake in shares of SunLink Health Systems by 1,691.6% during the 1st quarter. Acadian Asset Management LLC now owns 162,765 shares of the company’s stock valued at $443,000 after buying an additional 153,680 shares during the last quarter. Hedge funds and other institutional investors own 10.16% of the company’s stock.

SunLink Health Systems Company Profile

SunLink Health Systems, Inc, through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates through two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates an 84-bed community hospital, which includes an 18-bed geriatric psychiatry unit and a 66-bed nursing home in Mississippi; as well as offers information technology services.

Featured Article: Key terms to understand channel trading

Receive News & Ratings for SunLink Health Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SunLink Health Systems and related companies with MarketBeat.com's FREE daily email newsletter.